Biosimilars in the US Oncology Market Report: Data and Insights from 101 US-Based, Board-Certified Oncologists or Hematologist Oncologists - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Biosimilars in the US Oncology Market (2nd Edition)" report to their offering.

This report provides data and insights from 101 US-based, board-certified oncologists or hematologist oncologists as to their expectations, fears, and aspirations for biosimilars in oncology.

Use the data contained in this report to better understand how US-based oncologists will make prescribing decisions in a marketplace that includes biosimilar oncology options and how this has changed since 2012.

What You Will Learn:

- Familiarity with biosimilars

- Expected pricing/discount levels

- Preferred primary endpoints

- Influence the manufacturer plays in the prescribing decision

- How the data have changed since 2012

How You Can Use This Report:

- Use this report to inform your market access strategies, reimbursement plans, and manufacturing capacity planning.

- Better inform your sales and marketing efforts by understanding the benefits and barriers physicians see in prescribing biosimilars.

Key Topics Covered:

1. Introduction

2. Methodology

3. Statistical Significance

4. Respondent Qualifications

5. Summary Findings

6. Study Data

For more information about this report visit http://www.researchandmarkets.com/research/wdbmkf/biosimilars_in

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biosimilars and Biosuperiors

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biosimilars and Biosuperiors